Elaine O'Hara's most recent trade in Novavax, Inc. was a trade of 253,500 2025 Non-statutory Stock Option NQ done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 253,500 | 253,500 | - | - | 2025 Non-statutory Stock Option NQ | |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 169,000 | 169,000 | - | - | 2025 Restricted Stock Units RSU | |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 40,000 | 80,000 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 40,000 | 73,825 (0%) | 0% | 0 | Common Stock | |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 19,600 | 19,600 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 19,600 | 33,825 (0%) | 0% | 0 | Common Stock | |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 01 Mar 2025 | 10,969 | 57,481 (0%) | 0% | 8.3 | 91,372 | Common Stock |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 01 Mar 2025 | 5,375 | 68,450 (0%) | 0% | 8.3 | 44,774 | Common Stock |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 120,000 | 120,000 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.39 per share. | 01 Mar 2024 | 19,600 | 19,600 (0%) | 0% | 5.4 | 105,644 | Common Stock |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 19,600 | 39,200 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.39 per share. | 01 Mar 2024 | 5,375 | 14,225 (0%) | 0% | 5.4 | 28,971 | Common Stock |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 67,900 | 67,900 | - | - | Stock Option (Right to buy) | |
| Novavax, Inc. | Elaine O'Hara | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 58,800 | 58,800 | - | - | Restricted Stock Units |